Spero Therapeutics, Inc. Other Accrued Liabilities, Current
Spero Therapeutics, Inc. (SPRO) had Other Accrued Liabilities, Current of $90.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Other Accrued Liabilities, Current $90.00K.
- 2026-03-31: Other Accrued Liabilities, Current $75.00K.
- 2025-12-31: Other Accrued Liabilities, Current $133.00K.
- 2025-09-30: Other Accrued Liabilities, Current $82.00K.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $90.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $75.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $133.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $82.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $89.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $102.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $120.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $190.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $109.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $208.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $236.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $163.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $171.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $209.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $211.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $516.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.06M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.24M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.28M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $200.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $298.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $222.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $838.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $390.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $429.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $409.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $554.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $543.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $635.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $426.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $510.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $384.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $493.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $304.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $252.00K 10-Q · filed 2017-12-14 |
| 2016-12-31 | $221.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |